Cargando…
Biosimilar insulins: Informed choice for South Asia
Autores principales: | Kalra, Sanjay, Azad Khan, A. K., Raza, Syed Abbas, Somasundaram, Noel, Shrestha, Dina, Latif, Zafar Ahmed, Bajaj, Sarita, Pathan, >Md. Faruque, Sahay, Rakesh, Mahtab, Hajera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743384/ https://www.ncbi.nlm.nih.gov/pubmed/26904463 http://dx.doi.org/10.4103/2230-8210.164033 |
Ejemplares similares
-
The Dhaka Declaration 2015
por: Mahtab, Hajera, et al.
Publicado: (2015) -
Place of sulfonylureas in the management of type 2 diabetes mellitus in South Asia: A consensus statement
por: Kalra, Sanjay, et al.
Publicado: (2015) -
Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines
por: Baruah, Manash P., et al.
Publicado: (2011) -
South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome
por: Kalra, Sanjay, et al.
Publicado: (2011) -
South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan
por: Pathan, Md Faruque, et al.
Publicado: (2012)